ONL Therapeutics Starts Global Phase 2 GALAXY Trial
16 Mar 2026 //
PR NEWSWIRE
ONL Therapeutics Publishes Phase 1B Data On Xelafaslatide
09 Dec 2025 //
GLOBENEWSWIRE
ONL Therapeutics Starts Global Phase 2 GALAXY Trial of ONL1204
28 Oct 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support